BePharBel Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 68
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4.51M
Latest Deal Amount
  • Investors
  • 13

BePharBel General Information

Description

Manufacturer of pharmaceutical and para-pharmaceutical products intended to provide efficient and reliable medicines at accessible prices. The company's products meet both stringent and regulated European standards and provide generic drugs, including tablets, oral liquids and injectables, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 13 Rue du Luxembourg
  • 6180 Courcelles
  • Belgium
+32 071 00 00 00

BePharBel Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BePharBel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 27-Jun-2019 $4.51M 000.00 000.00 Completed Generating Revenue
9. Debt - General 01-Mar-2019 00000 000.00 Completed Generating Revenue
8. Debt - General 00.000 000.00 Completed Generating Revenue
7. Debt - General 00000 000.00 Completed Generating Revenue
6. Later Stage VC 08-Nov-2018 00.000 000.00 000.00 Completed Generating Revenue
5. Early Stage VC 22-Jun-2016 00.000 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 14-Jul-2015 00.00 Completed Generating Revenue
3. Early Stage VC 26-Jun-2014 00.000 00.00 000.00 Completed Generating Revenue
2. Early Stage VC 25-Jul-2013 $556K $1.01M 00.000 Completed Generating Revenue
1. Early Stage VC 03-Oct-2012 $452K $452K 00.000 Completed Generating Revenue
To view BePharBel’s complete valuation and funding history, request access »

BePharBel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 000.00 000.00 00 000.00 000
Ordinary 000,000 000.0 000.0 00 000.0 00.000
Ordinary 18,940 $25.35 $25.35 1x $25.35 4.95%
Ordinary 23,340 $16.9 $16.9 1x $16.9 6.1%
To view BePharBel’s complete cap table history, request access »

BePharBel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of pharmaceutical and para-pharmaceutical products intended to provide efficient and reliable medicines at
Pharmaceuticals
Courcelles, Belgium
68 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

00000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Florence, Italy
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BePharBel Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 000000000 Private Equity-Backed Florence, Italy 00 000000000000
You’re viewing 1 of 1 competitors. Get the full list »

BePharBel Executive Team (6)

Name Title Board Seat Contact Info
Arnaud Navez Chief Financial Officer
Olivier Vanloocke Chief Operating Officer
Vincent Stephenne Ph.D Managing Director & Board Member
Jean Stephenne President & Board Member
You’re viewing 4 of 6 executive team members. Get the full list »

BePharBel Board Members (11)

Name Representing Role Since
Anne Prignon SambrInvest Board Member 000 0000
Antoine de Mortemart Self Board Member 000 0000
Bernard Jolly Nomainvest Board Member 000 0000
Cyril Wolkonsky Self Board Member 000 0000
Fabrice Carosella SambrInvest Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

BePharBel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BePharBel Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Société Régionale d'Investissement de Wallonie Growth/Expansion Minority 000 0000 000000 0
Alain Parthoens Angel (individual) Minority 000 0000 000000 0
Antoine de Mortemart Angel (individual) Minority 000 0000 000000 0
Christian Vandecasserie Angel (individual) Minority 000 0000 000000 0
Cyril Wolkonsky Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

BePharBel Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000 06-Mar-2014 000000000000000000 Other Healthcare Services
To view BePharBel’s complete acquisitions history, request access »